港股异动 | 和铂医药-B(02142)仍跌2% 与百时美施贵宝达成全球战略合作 潜在收益超10亿美元

智通财经
Dec 17, 2025

智通财经APP获悉,和铂医药-B(02142)小幅高开后走低,一度跌超5%,现跌幅收窄。截至发稿,跌2.08%,报12.72港元,成交额3645.09万港元。

消息面上,和铂医药今早宣布,与百时美施贵宝达成长期全球战略合作及许可协议,双方将共同研发新一代多特异性抗体疗法。根据协议条款,和铂医药将与百时美施贵宝合作推进及加速多特异性抗体发现项目。和铂医药将获得总计9000万美元的付款,若百时美施贵宝选择推进所有潜在项目,和铂医药还可获得高达10.35亿美元的开发及商业里程碑付款,以及基于未来产品净销售额的分级特许权使用费。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10